BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27042848)

  • 21. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transplant diabetes mellitus.
    Chowdhury TA
    Clin Med (Lond); 2019 Sep; 19(5):392-395. PubMed ID: 31530687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early hyperglycemia: a risk factor for posttransplant diabetes mellitus among renal transplant recipients.
    Maldonado F; Tapia G; Ardiles L
    Transplant Proc; 2009; 41(6):2664-7. PubMed ID: 19715996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
    Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
    Sheean P; Braunschweig C
    JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early hyperglycemia after allogenic kidney transplantation.
    Wyzgal J; Paczek L; Ziolkowski J; Pawlowska M; Rowiński W; Durlik M
    Ann Transplant; 2007; 12(1):40-5. PubMed ID: 17953142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
    Ollech JE; Kramer MR; Peled N; Ollech A; Amital A; Medalion B; Saute M; Shitrit D
    Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial Response to New-Onset Diabetes as a Long-Term Effect of Allogeneic Hematopoietic Stem Cell Transplantation.
    Olausson JM; Clark L; Morse JM; Hammer M; Allen N; Grant M
    Qual Health Res; 2017 Oct; 27(12):1816-1827. PubMed ID: 28728478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment and management of post-transplant diabetes mellitus.
    Han E; Kim MS; Kim YS; Kang ES
    Metabolism; 2016 Oct; 65(10):1559-69. PubMed ID: 27621191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.
    Liu J; Zhong JF; Zhang X; Zhang C
    J Hematol Oncol; 2017 Jan; 10(1):35. PubMed ID: 28143567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Mori S; Fukuda T; Kamiya S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Honda O; Kuwahara S; Tanosaki R; Heike Y; Tobinai K; Takaue Y
    Transplantation; 2007 Oct; 84(7):814-20. PubMed ID: 17984832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.
    Shivaswamy V; Boerner B; Larsen J
    Endocr Rev; 2016 Feb; 37(1):37-61. PubMed ID: 26650437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-transplant diabetes: diagnosis and management.
    Boerner BP; Shivaswamy V; Wolatz E; Larsen J
    Minerva Endocrinol; 2018 Jun; 43(2):198-211. PubMed ID: 28990741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
    Sobiak J; Kazimierczak U; Kowalczyk DW; Chrzanowska M; Styczyński J; Wysocki M; Szpecht D; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):385-95. PubMed ID: 26040247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.